Predictive Analysis for Identifying Potentially Undiagnosed Post-stroke Spasticity Patients in United Kingdom
Overview
Authors
Affiliations
Purpose Of The Research: Spasticity is one of the well-recognized complications of stroke which may give rise to pain and limit patients' ability to perform daily activities. The predisposing factors and direct effects of post-stroke spasticity also involve high management costs in terms of healthcare resources, and case-control designs are required for establishing such differences. Using 'The Health Improvement Network' (THIN) database, such a study would not provide reliable estimates since the prevalence of post-stroke spasticity was found to be 2%, substantially below the most conservative previously reported estimates. The objective of this study was to use predictive analysis techniques to determine if there are a substantial number of potentially under-recorded patients with post-stroke spasticity.
Methods: This study used retrospective data from adult patients with a diagnostic code for stroke between 2007 and 2011 registered in THIN. Two algorithm approaches were developed and compared, a statistically validated data-trained algorithm and a clinician-trained algorithm.
Results: A data-trained algorithm using Random Forest showed better prediction performance than clinician-trained algorithm, with higher sensitivity and only marginally lower specificity. Overall accuracy was 75% and 72%, respectively. The data-trained algorithm predicted an additional 3912 records consistent with patients developing spasticity in the 12months following a stroke.
Conclusions: Using machine learning techniques, additional unrecorded post-stroke spasticity patients were identified, increasing the condition's prevalence in THIN from 2% to 13%. This work shows the potential for under-reporting of PSS in primary care data, and provides a method for improved identification of cases and control records for future studies.
Anton M, Molina M, Perez J, Pina S, Tapiador N, De La Calle B Toxins (Basel). 2024; 16(8).
PMID: 39195750 PMC: 11359065. DOI: 10.3390/toxins16080340.
Morone G, Baricich A, Paolucci S, Bentivoglio A, De Blasiis P, Carlucci M Healthcare (Basel). 2023; 11(6).
PMID: 36981442 PMC: 10048278. DOI: 10.3390/healthcare11060783.
Huang J, He W, Xu H, Yang S, Dai J, Guo W J Healthc Eng. 2023; 2023:8964676.
PMID: 36794098 PMC: 9925238. DOI: 10.1155/2023/8964676.
Zhang X, Fei N, Zhang X, Wang Q, Fang Z Front Aging Neurosci. 2022; 14:897611.
PMID: 35923545 PMC: 9341133. DOI: 10.3389/fnagi.2022.897611.
Persson C, Hansson P Sci Rep. 2021; 11(1):24035.
PMID: 34911990 PMC: 8674218. DOI: 10.1038/s41598-021-03375-9.